Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Alzheimer's Disease

  Free Subscription


Articles published in Arch Neurol

Retrieve available abstracts of 88 articles:
HTML format
Text format



Single Articles


    January 2012
  1. VAN HIMBERGEN TM , Beiser AS, Ai M, Seshadri S, et al
    Biomarkers for Insulin Resistance and Inflammation and the Risk for All-Cause Dementia and Alzheimer Disease: Results From the Framingham Heart Study.
    Arch Neurol. 2012.
    PubMed     Text format     Related articles    Abstract available



  2. RINGMAN JM , Schulman H, Becker C, Jones T, et al
    Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations.
    Arch Neurol. 2012;69:96-104.
    PubMed     Text format     Related articles    Abstract available



    December 2011
  3. LOGUE MW , Schu M, Vardarajan BN, Buros J, et al
    A Comprehensive Genetic Association Study of Alzheimer Disease in African Americans.
    Arch Neurol. 2011;68:1569-1579.
    PubMed     Text format     Related articles    Abstract available



    November 2011
  4. SABBAGH MN , Fleisher A, Chen K, Rogers J, et al
    Positron Emission Tomography and Neuropathologic Estimates of Fibrillar Amyloid-beta in a Patient With Down Syndrome and Alzheimer Disease.
    Arch Neurol. 2011;68:1461-6.
    PubMed     Text format     Related articles    Abstract available



  5. HARDY J , Guerreiro R, Lovestone S
    Clusterin as an Alzheimer biomarker.
    Arch Neurol. 2011;68:1459-60.
    PubMed     Text format     Related articles   



  6. SHEPARDSON NE , Shankar GM, Selkoe DJ
    Cholesterol Level and Statin Use in Alzheimer Disease: II. Review of Human Trials and Recommendations.
    Arch Neurol. 2011;68:1385-92.
    PubMed     Text format     Related articles    Abstract available



  7. JAGUST WJ
    Amyloid imaging: liberal or conservative? Let the data decide.
    Arch Neurol. 2011;68:1377-8.
    PubMed     Text format     Related articles   



    October 2011
  8. OSTROWITZKI S , Deptula D, Thurfjell L, Barkhof F, et al
    Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  9. XIONG C , Roe CM, Buckles V, Fagan A, et al
    Role of family history for Alzheimer biomarker abnormalities in the adult children study.
    Arch Neurol. 2011;68:1313-9.
    PubMed     Text format     Related articles    Abstract available



  10. SHEPARDSON NE , Shankar GM, Selkoe DJ
    Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies.
    Arch Neurol. 2011;68:1239-44.
    PubMed     Text format     Related articles    Abstract available



  11. LO RY , Hubbard AE, Shaw LM, Trojanowski JQ, et al
    Longitudinal change of biomarkers in cognitive decline.
    Arch Neurol. 2011;68:1257-66.
    PubMed     Text format     Related articles    Abstract available



    September 2011
  12. WINGO TS , Lah JJ, Levey AI, Cutler DJ, et al
    Autosomal Recessive Causes Likely in Early-Onset Alzheimer Disease.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  13. CRAFT S , Baker LD, Montine TJ, Minoshima S, et al
    Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment: A Pilot Clinical Trial.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  14. MULLER U , Winter P, Graeber MB
    Alois Alzheimer's Case, Auguste D., Did Not Carry the N141I Mutation in PSEN2 Characteristic of Alzheimer Disease in Volga Germans.
    Arch Neurol. 2011;68:1210-1.
    PubMed     Text format     Related articles   



  15. SCHMIDT C , Wolff M, Weitz M, Bartlau T, et al
    Rapidly progressive Alzheimer disease.
    Arch Neurol. 2011;68:1124-30.
    PubMed     Text format     Related articles    Abstract available



  16. ROE CM , Fagan AM, Grant EA, Marcus DS, et al
    Cerebrospinal fluid biomarkers, education, brain volume, and future cognition.
    Arch Neurol. 2011;68:1145-51.
    PubMed     Text format     Related articles    Abstract available



    August 2011
  17. JACK CR JR , Vemuri P, Wiste HJ, Weigand SD, et al
    Evidence for Ordering of Alzheimer Disease Biomarkers.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  18. SABUNCU MR , Desikan RS, Sepulcre J, Yeo BT, et al
    The Dynamics of Cortical and Hippocampal Atrophy in Alzheimer Disease.
    Arch Neurol. 2011;68:1040-1048.
    PubMed     Text format     Related articles    Abstract available



  19. CRUCHAGA C , Nowotny P, Kauwe JS, Ridge PG, et al
    Association and Expression Analyses With Single-Nucleotide Polymorphisms in TOMM40 in Alzheimer Disease.
    Arch Neurol. 2011;68:1013-1019.
    PubMed     Text format     Related articles    Abstract available



  20. SONNEN JA , Santa Cruz K, Hemmy LS, Woltjer R, et al
    Ecology of the aging human brain.
    Arch Neurol. 2011;68:1049-56.
    PubMed     Text format     Related articles    Abstract available



    July 2011
  21. FLEISHER AS , Chen K, Liu X, Roontiva A, et al
    Using Positron Emission Tomography and Florbetapir F 18 to Image Cortical Amyloid in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer Disease.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  22. VILLEMAGNE VL , Okamura N, Pejoska S, Drago J, et al
    In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease.
    Arch Neurol. 2011;68:905-12.
    PubMed     Text format     Related articles    Abstract available



  23. LANDT J , D'Abrera JC, Holland AJ, Aigbirhio FI, et al
    Using positron emission tomography and Carbon 11-labeled Pittsburgh Compound B to image Brain Fibrillar beta-amyloid in adults with down syndrome: safety, acceptability, and feasibility.
    Arch Neurol. 2011;68:890-6.
    PubMed     Text format     Related articles    Abstract available



    June 2011
  24. ROSENBERG RN
    Treat Alzheimer Disease Before It Is Symptomatic.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles   



  25. HACHINSKI V
    Stroke and Alzheimer disease: fellow travelers or partners in crime?
    Arch Neurol. 2011;68:797-8.
    PubMed     Text format     Related articles   



  26. NELSON LD , Siddarth P, Kepe V, Scheibel KE, et al
    Positron emission tomography of brain beta-amyloid and tau levels in adults with Down syndrome.
    Arch Neurol. 2011;68:768-74.
    PubMed     Text format     Related articles    Abstract available



  27. BAYER-CARTER JL , Green PS, Montine TJ, VanFossen B, et al
    Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment.
    Arch Neurol. 2011;68:743-52.
    PubMed     Text format     Related articles    Abstract available



    May 2011
  28. FAGAN AM , Shaw LM, Xiong C, Vanderstichele H, et al
    Comparison of Analytical Platforms for Cerebrospinal Fluid Measures of {beta}-Amyloid 1-42, Total tau, and P-tau181 for Identifying Alzheimer Disease Amyloid Plaque Pathology.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  29. DAVIGLUS ML , Plassman BL, Pirzada A, Bell CC, et al
    Risk Factors and Preventive Interventions for Alzheimer Disease: State of the Science.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  30. LASKE C
    Blood-based biomarkers in Alzheimer disease.
    Arch Neurol. 2011;68:685-6.
    PubMed     Text format     Related articles   



  31. ATRI A , O'Brien JL, Sreenivasan A, Rastegar S, et al
    Test-retest reliability of memory task functional magnetic resonance imaging in Alzheimer disease clinical trials.
    Arch Neurol. 2011;68:599-606.
    PubMed     Text format     Related articles    Abstract available



  32. YAFFE K , Middleton LE, Lui LY, Spira AP, et al
    Mild cognitive impairment, dementia, and their subtypes in oldest old women.
    Arch Neurol. 2011;68:631-6.
    PubMed     Text format     Related articles    Abstract available



  33. CRUCHAGA C , Graff C, Chiang HH, Wang J, et al
    Association of TMEM106B gene polymorphism with age at onset in granulin mutation carriers and plasma granulin protein levels.
    Arch Neurol. 2011;68:581-6.
    PubMed     Text format     Related articles    Abstract available



    April 2011
  34. HYMAN BT
    Amyloid-Dependent and Amyloid-Independent Stages of Alzheimer Disease.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles   



  35. SCHNEIDER LS , Dagerman KS, Higgins JP, McShane R, et al
    Lack of Evidence for the Efficacy of Memantine in Mild Alzheimer Disease.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available



  36. SAKURAI T
    Targets of the Peroxisome Proliferator-Activated Receptor {gamma} Agonist Trials for the Prevention of Alzheimer Disease.
    Arch Neurol. 2011;68:542.
    PubMed     Text format     Related articles   



    March 2011
  37. WILSON RS , Leurgans SE, Boyle PA, Bennett DA, et al
    Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment.
    Arch Neurol. 2011;68:351-6.
    PubMed     Text format     Related articles    Abstract available



  38. OKEREKE OI , Copeland M, Hyman BT, Wanggaard T, et al
    The Structured Interview & Scoring Tool-Massachusetts Alzheimer's Disease Research Center (SIST-M): Development, Reliability, and Cross-Sectional Validation of a Brief Structured Clinical Dementia Rating Interview.
    Arch Neurol. 2011;68:343-50.
    PubMed     Text format     Related articles    Abstract available



  39. KUHLMANN D
    Primum non nocere.
    Arch Neurol. 2011;68:397-8.
    PubMed     Text format     Related articles   



  40. SETO-SALVIA N , Clarimon J, Pagonabarraga J, Pascual-Sedano B, et al
    Dementia Risk in Parkinson Disease: Disentangling the Role of MAPT Haplotypes.
    Arch Neurol. 2011;68:359-64.
    PubMed     Text format     Related articles    Abstract available



  41. WOMACK KB , Diaz-Arrastia R, Aizenstein HJ, Arnold SE, et al
    Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors.
    Arch Neurol. 2011;68:329-37.
    PubMed     Text format     Related articles    Abstract available



    February 2011
  42. BARNES DE , Yaffe K
    Accuracy of summary risk score for prediction of Alzheimer disease: better than demographics alone?
    Arch Neurol. 2011;68:268.
    PubMed     Text format     Related articles   



  43. REIJMER Y , Biessels GJ
    Vascular risk scores for dementia: age matters.
    Arch Neurol. 2011;68:267.
    PubMed     Text format     Related articles   



  44. GEERLINGS MI , Vergouwe Y
    Improving risk scores for dementia.
    Arch Neurol. 2011;68:267-8.
    PubMed     Text format     Related articles   



  45. SOJKOVA J , Driscoll I, Iacono D, Zhou Y, et al
    In vivo fibrillar beta-amyloid detected using [11C]PiB positron emission tomography and neuropathologic assessment in older adults.
    Arch Neurol. 2011;68:232-40.
    PubMed     Text format     Related articles    Abstract available



    January 2011
  46. REITZ C , Cheng R, Rogaeva E, Lee JH, et al
    Meta-analysis of the Association Between Variants in SORL1 and Alzheimer Disease.
    Arch Neurol. 2011;68:99-106.
    PubMed     Text format     Related articles    Abstract available



  47. SCHNEIDER LS , Insel PS, Weiner MW
    Treatment With Cholinesterase Inhibitors and Memantine of Patients in the Alzheimer's Disease Neuroimaging Initiative.
    Arch Neurol. 2011;68:58-66.
    PubMed     Text format     Related articles    Abstract available



  48. SALLOWAY S
    New lessons from the Alzheimer's disease neuroimaging initiative.
    Arch Neurol. 2011;68:19-21.
    PubMed     Text format     Related articles   



  49. LUCHSINGER JA , Small S, Biessels GJ
    Should we target insulin resistance to prevent dementia due to Alzheimer disease?
    Arch Neurol. 2011;68:17-8.
    PubMed     Text format     Related articles   



  50. OKONKWO OC , Mielke MM, Griffith HR, Moghekar AR, et al
    Cerebrospinal fluid profiles and prospective course and outcome in patients with amnestic mild cognitive impairment.
    Arch Neurol. 2011;68:113-9.
    PubMed     Text format     Related articles    Abstract available



  51. NERVI A , Reitz C, Tang MX, Santana V, et al
    Familial aggregation of dementia with Lewy bodies.
    Arch Neurol. 2011;68:90-3.
    PubMed     Text format     Related articles    Abstract available



    December 2010
  52. REITZ C , Tang MX, Schupf N, Manly JJ, et al
    Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease.
    Arch Neurol. 2010;67:1491-7.
    PubMed     Text format     Related articles    Abstract available



  53. GABEL MJ , Foster NL, Heidebrink JL, Higdon R, et al
    Validation of consensus panel diagnosis in dementia.
    Arch Neurol. 2010;67:1506-12.
    PubMed     Text format     Related articles    Abstract available



    November 2010
  54. LEE JH , Cheng R, Barral S, Reitz C, et al
    Identification of Novel Loci for Alzheimer Disease and Replication of CLU, PICALM, and BIN1 in Caribbean Hispanic Individuals.
    Arch Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  55. CARMICHAEL O , Schwarz C, Drucker D, Fletcher E, et al
    Longitudinal Changes in White Matter Disease and Cognition in the First Year of the Alzheimer Disease Neuroimaging Initiative.
    Arch Neurol. 2010;67:1370-1378.
    PubMed     Text format     Related articles    Abstract available



  56. STORANDT M , Morris JC
    Ascertainment bias in the clinical diagnosis of Alzheimer disease.
    Arch Neurol. 2010;67:1364-9.
    PubMed     Text format     Related articles    Abstract available



    October 2010
  57. SOLFRIZZI V , Frisardi V, Seripa D, Capurso C, et al
    Dietary patterns and protection against Alzheimer disease and cognitive decline.
    Arch Neurol. 2010;67:1285-6.
    PubMed     Text format     Related articles   



  58. JAEGER PA , Wyss-Coray T
    Beclin 1 complex in autophagy and Alzheimer disease.
    Arch Neurol. 2010;67:1181-4.
    PubMed     Text format     Related articles    Abstract available



    September 2010
  59. GELDMACHER DS , Fritsch T, McClendon MJ, Landreth G, et al
    A Randomized Pilot Clinical Trial of the Safety of Pioglitazone in Treatment of Patients With Alzheimer Disease.
    Arch Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  60. BAKER LD , Cross DJ, Minoshima S, Belongia D, et al
    Insulin Resistance and Alzheimer-like Reductions in Regional Cerebral Glucose Metabolism for Cognitively Normal Adults With Prediabetes or Early Type 2 Diabetes.
    Arch Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  61. O'BRYANT SE , Xiao G, Barber R, Reisch J, et al
    A Serum Protein-Based Algorithm for the Detection of Alzheimer Disease.
    Arch Neurol. 2010;67:1077-1081.
    PubMed     Text format     Related articles    Abstract available



    August 2010
  62. JUN G , Naj AC, Beecham GW, Wang LS, et al
    Meta-analysis Confirms CR1, CLU, and PICALM as Alzheimer Disease Risk Loci and Reveals Interactions With APOE Genotypes.
    Arch Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  63. ALVAREZ-ERVITI L , Rodriguez-Oroz MC, Cooper JM, Caballero C, et al
    Chaperone-Mediated Autophagy Markers in Parkinson Disease Brains.
    Arch Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  64. DE MEYER G , Shapiro F, Vanderstichele H, Vanmechelen E, et al
    Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People.
    Arch Neurol. 2010;67:949-956.
    PubMed     Text format     Related articles    Abstract available



  65. GEDA YE
    A purpose-oriented life: is it potentially neuroprotective?
    Arch Neurol. 2010;67:1010-1.
    PubMed     Text format     Related articles   



  66. HERSKOVITS AZ , Growdon JH
    Sharpen that needle.
    Arch Neurol. 2010;67:918-20.
    PubMed     Text format     Related articles   



    July 2010
  67. FOTUHI M
    The challenge and public health implications of Alzheimer overdiagnosis in the oldest old.
    Arch Neurol. 2010;67:899.
    PubMed     Text format     Related articles   



  68. AHIMA RS
    Connecting leptin and Alzheimer disease.
    Arch Neurol. 2010;67:873-5.
    PubMed     Text format     Related articles   



  69. WILSON RS , Leurgans SE, Foroud TM, Sweet RA, et al
    Telephone Assessment of Cognitive Function in the Late-Onset Alzheimer's Disease Family Study.
    Arch Neurol. 2010;67:855-861.
    PubMed     Text format     Related articles    Abstract available



  70. REITZ C , Tang MX, Schupf N, Manly JJ, et al
    A summary risk score for the prediction of Alzheimer disease in elderly persons.
    Arch Neurol. 2010;67:835-41.
    PubMed     Text format     Related articles    Abstract available



    June 2010
  71. CARRASQUILLO MM , Belbin O, Hunter TA, Ma L, et al
    Replication of CLU, CR1, and PICALM Associations With Alzheimer Disease.
    Arch Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  72. O'BRYANT SE , Lacritz LH, Hall J, Waring SC, et al
    Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer's coordinating center database.
    Arch Neurol. 2010;67:746-9.
    PubMed     Text format     Related articles    Abstract available



  73. OKONKWO OC , Alosco ML, Griffith HR, Mielke MM, et al
    Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer disease.
    Arch Neurol. 2010;67:688-96.
    PubMed     Text format     Related articles    Abstract available



  74. BIFFI A , Anderson CD, Desikan RS, Sabuncu M, et al
    Genetic variation and neuroimaging measures in Alzheimer disease.
    Arch Neurol. 2010;67:677-85.
    PubMed     Text format     Related articles    Abstract available



  75. HARDY J , Williams J
    Identification of Alzheimer risk factors through whole-genome analysis.
    Arch Neurol. 2010;67:663-4.
    PubMed     Text format     Related articles   



    May 2010
  76. YU CE , Marchani E, Nikisch G, Muller U, et al
    The N141I mutation in PSEN2: implications for the quintessential case of Alzheimer disease.
    Arch Neurol. 2010;67:631-3.
    PubMed     Text format     Related articles    Abstract available



  77. ROSES AD
    An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease.
    Arch Neurol. 2010;67:536-41.
    PubMed     Text format     Related articles    Abstract available



  78. NASLUND J
    Visuospatial ability in relation to fall risk and dementia.
    Arch Neurol. 2010;67:643.
    PubMed     Text format     Related articles   



    April 2010
  79. GU Y , Nieves JW, Stern Y, Luchsinger JA, et al
    Food Combination and Alzheimer Disease Risk: A Protective Diet.
    Arch Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  80. LANGBAUM JB , Chen K, Caselli RJ, Lee W, et al
    Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.
    Arch Neurol. 2010;67:462-8.
    PubMed     Text format     Related articles    Abstract available



  81. BURNS JM , Johnson DK, Watts A, Swerdlow RH, et al
    Reduced lean mass in early Alzheimer disease and its association with brain atrophy.
    Arch Neurol. 2010;67:428-33.
    PubMed     Text format     Related articles    Abstract available



  82. KERTESZ A , Jesso S, Harciarek M, Blair M, et al
    What is semantic dementia?: a cohort study of diagnostic features and clinical boundaries.
    Arch Neurol. 2010;67:483-9.
    PubMed     Text format     Related articles    Abstract available



    February 2010
  83. KELLEY BJ , Haidar W, Boeve BF, Baker M, et al
    Alzheimer Disease-like Phenotype Associated With the c.154delA Mutation in Progranulin.
    Arch Neurol. 2010;67:171-7.
    PubMed     Text format     Related articles    Abstract available



    January 2010
  84. GANGULI M , Kukull WA
    Lost in translation: epidemiology, risk, and Alzheimer disease.
    Arch Neurol. 2010;67:107-11.
    PubMed     Text format     Related articles   



  85. WANG L , Harms MP, Staggs JM, Xiong C, et al
    Donepezil treatment and changes in hippocampal structure in very mild Alzheimer disease.
    Arch Neurol. 2010;67:99-106.
    PubMed     Text format     Related articles    Abstract available



  86. THAMBISETTY M , Beason-Held L, An Y, Kraut MA, et al
    APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging.
    Arch Neurol. 2010;67:93-8.
    PubMed     Text format     Related articles    Abstract available



  87. GEDA YE , Roberts RO, Knopman DS, Christianson TJ, et al
    Physical exercise, aging, and mild cognitive impairment: a population-based study.
    Arch Neurol. 2010;67:80-6.
    PubMed     Text format     Related articles    Abstract available



  88. BAKER LD , Frank LL, Foster-Schubert K, Green PS, et al
    Effects of aerobic exercise on mild cognitive impairment: a controlled trial.
    Arch Neurol. 2010;67:71-9.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: